ALB and Sepsis: Overall, 126 out of 186 patients (67.7%) in this study were administered albumin for an appropriate indication as defined by our criteria utilizing the FDA-labeled indications, Surviving Sepsis Campaign guidelines, and the study by Buckley and colleagues [9].